Annual Accounts Payable
$6.43 M
-$6.54 M-50.43%
31 December 2023
Summary:
VBI Vaccines annual accounts payable is currently $6.43 million, with the most recent change of -$6.54 million (-50.43%) on 31 December 2023. During the last 3 years, it has risen by +$2.70 million (+72.23%).VBIV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$8.87 M
+$2.44 M+37.94%
31 March 2024
Summary:
VBI Vaccines quarterly accounts payable is currently $8.87 million, with the most recent change of +$2.44 million (+37.94%) on 31 March 2024. Over the past year, it has increased by +$1.86 million (+26.58%).VBIV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.4% | +26.6% |
| 3 y3 years | +72.2% | +136.9% |
| 5 y5 years | +6.2% | +178.3% |
VBIV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -50.4% | -31.6% |
VBI Vaccines Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $8.87 M(+37.9%) |
| Dec 2023 | $6.43 M(-50.4%) | $6.43 M(-8.2%) |
| Sept 2023 | - | $7.01 M(-4.7%) |
| June 2023 | - | $7.35 M(-25.3%) |
| Mar 2023 | - | $9.84 M(-24.2%) |
| Dec 2022 | $12.97 M(+203.1%) | $12.97 M(+11.2%) |
| Sept 2022 | - | $11.67 M(+107.7%) |
| June 2022 | - | $5.62 M(+43.0%) |
| Mar 2022 | - | $3.93 M(-8.2%) |
| Dec 2021 | $4.28 M(+14.6%) | $4.28 M(+14.3%) |
| Sept 2021 | - | $3.75 M(+117.1%) |
| June 2021 | - | $1.73 M(+3.4%) |
| Mar 2021 | - | $1.67 M(-55.3%) |
| Dec 2020 | $3.73 M(+231.3%) | $3.73 M(+11.3%) |
| Sept 2020 | - | $3.36 M(+40.3%) |
| June 2020 | - | $2.39 M(+82.2%) |
| Mar 2020 | - | $1.31 M(+16.5%) |
| Dec 2019 | $1.13 M(-81.4%) | $1.13 M(-64.6%) |
| Sept 2019 | - | $3.19 M(-1.5%) |
| June 2019 | - | $3.23 M(-42.8%) |
| Mar 2019 | - | $5.65 M(-6.6%) |
| Dec 2018 | $6.05 M(+234.5%) | $6.05 M(+34.3%) |
| Sept 2018 | - | $4.51 M(+49.0%) |
| June 2018 | - | $3.03 M(+19.3%) |
| Mar 2018 | - | $2.54 M(+40.2%) |
| Dec 2017 | $1.81 M(-10.3%) | $1.81 M(-47.5%) |
| Sept 2017 | - | $3.45 M(+46.5%) |
| June 2017 | - | $2.35 M(+59.0%) |
| Mar 2017 | - | $1.48 M(-26.7%) |
| Dec 2016 | $2.02 M(+394.6%) | $2.02 M(-70.5%) |
| Sept 2016 | - | $6.84 M(+16.7%) |
| June 2016 | - | $5.86 M(+782.4%) |
| Mar 2016 | - | $664.00 K(+62.7%) |
| Dec 2015 | $408.00 K(+77.9%) | $408.00 K(-16.2%) |
| Sept 2015 | - | $487.00 K(-2.1%) |
| June 2015 | - | $497.60 K(+116.9%) |
| Mar 2015 | - | $229.40 K(+78.2%) |
| Mar 2015 | $229.40 K(+31.2%) | - |
| Dec 2014 | - | $128.70 K(+17.6%) |
| Sept 2014 | - | $109.40 K(-30.6%) |
| June 2014 | - | $157.70 K(-9.8%) |
| Mar 2014 | $174.90 K(+9.4%) | $174.90 K(+82.6%) |
| Dec 2013 | - | $95.80 K(+7.0%) |
| Sept 2013 | - | $89.50 K(+40.3%) |
| June 2013 | - | $63.80 K(-60.1%) |
| Mar 2013 | $159.90 K | $159.90 K(-40.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $268.00 K(+5.3%) |
| Sept 2012 | - | $254.50 K(+59.0%) |
| June 2012 | - | $160.10 K(-58.9%) |
| Mar 2012 | $389.50 K(-40.3%) | $389.50 K(+100.7%) |
| Dec 2011 | - | $194.10 K(-75.5%) |
| Sept 2011 | - | $793.60 K(+70.4%) |
| June 2011 | - | $465.60 K(-28.6%) |
| Mar 2011 | $651.90 K(+851.7%) | $651.90 K(+542.3%) |
| Dec 2010 | - | $101.50 K(+48.2%) |
| Mar 2010 | $68.50 K(+12.1%) | $68.50 K(+12.1%) |
| Mar 2009 | $61.10 K(+18.6%) | $61.10 K(+37.6%) |
| Sept 2008 | - | $44.40 K(-58.6%) |
| June 2008 | - | $107.20 K(+65.2%) |
| Dec 2007 | - | $64.90 K(-46.3%) |
| Sept 2007 | - | $120.80 K(+43.6%) |
| June 2007 | - | $84.10 K(+63.3%) |
| Mar 2007 | $51.50 K(-22.2%) | $51.50 K(+41.5%) |
| Dec 2006 | - | $36.40 K(+24.7%) |
| Sept 2006 | - | $29.20 K(-62.2%) |
| June 2006 | - | $77.20 K(+16.6%) |
| Mar 2006 | $66.20 K(-18.3%) | $66.20 K(-17.4%) |
| Dec 2005 | - | $80.10 K(+37.4%) |
| Sept 2005 | - | $58.30 K(+161.4%) |
| June 2005 | - | $22.30 K(-72.5%) |
| Mar 2005 | $81.00 K(+48.1%) | $81.00 K(+51.7%) |
| Dec 2004 | - | $53.40 K(+92.8%) |
| Sept 2004 | - | $27.70 K(-52.4%) |
| June 2004 | - | $58.20 K(+6.4%) |
| Mar 2004 | $54.70 K(-71.9%) | $54.70 K(-73.6%) |
| Dec 2003 | - | $206.90 K(+5.3%) |
| Sept 2003 | - | $196.50 K(-3.8%) |
| June 2003 | - | $204.20 K(+4.9%) |
| Mar 2003 | $194.70 K(+46.2%) | $194.70 K(+1654.1%) |
| Dec 2002 | - | $11.10 K(-28.4%) |
| Sept 2002 | - | $15.50 K(+19.2%) |
| June 2002 | - | $13.00 K(-90.2%) |
| Mar 2002 | $133.20 K(+188.9%) | $133.20 K(+44.5%) |
| Dec 2001 | - | $92.20 K(+15.4%) |
| Sept 2001 | - | $79.90 K(+37.0%) |
| June 2001 | - | $58.30 K(+26.5%) |
| Mar 2001 | $46.10 K(-77.7%) | $46.10 K(+12.7%) |
| Dec 2000 | - | $40.90 K(-4.9%) |
| Sept 2000 | - | $43.00 K(-79.2%) |
| Mar 2000 | $206.50 K(+55.8%) | $206.50 K(+55.8%) |
| Mar 1999 | $132.50 K(+88.2%) | $132.50 K(+88.2%) |
| Mar 1998 | $70.40 K | $70.40 K(+0.7%) |
| Dec 1997 | - | $69.90 K |
FAQ
- What is VBI Vaccines annual accounts payable?
- What is the all time high annual accounts payable for VBI Vaccines?
- What is VBI Vaccines annual accounts payable year-on-year change?
- What is VBI Vaccines quarterly accounts payable?
- What is the all time high quarterly accounts payable for VBI Vaccines?
- What is VBI Vaccines quarterly accounts payable year-on-year change?
What is VBI Vaccines annual accounts payable?
The current annual accounts payable of VBIV is $6.43 M
What is the all time high annual accounts payable for VBI Vaccines?
VBI Vaccines all-time high annual accounts payable is $12.97 M
What is VBI Vaccines annual accounts payable year-on-year change?
Over the past year, VBIV annual accounts payable has changed by -$6.54 M (-50.43%)
What is VBI Vaccines quarterly accounts payable?
The current quarterly accounts payable of VBIV is $8.87 M
What is the all time high quarterly accounts payable for VBI Vaccines?
VBI Vaccines all-time high quarterly accounts payable is $12.97 M
What is VBI Vaccines quarterly accounts payable year-on-year change?
Over the past year, VBIV quarterly accounts payable has changed by +$1.86 M (+26.58%)